UNSPSC 85813125: Introduction of other therapeutic substance into biliary and pancreatic tract, via natural or artificial opening

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of other therapeutic substance into biliary and pancreatic tract, via natural or artificial opening. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0J7GC

UNSPSC 85813125, Introduction of other therapeutic substance into biliary and pancreatic tract via natural or artificial opening, is a Commodity code with minimal recent state and local procurement activity directly aligned to its clinical scope. The recent opportunities tagged to this code show no pattern of actual solicitation for biliary or pancreatic interventional procedures; instead, they reflect a broad range of health services procurement spanning telehealth platforms, occupational health programs, cancer screening, EMS billing systems, recovery services, and employee wellness portals—none of which involve therapeutic substance introduction into biliary or pancreatic ducts.

State and local health systems are soliciting across fragmented service lines rather than specialized procedural services under this code. Issuing bodies include county health authorities (Inland Empire Health Plan in California, Brevard County in Florida, DeKalb County in Georgia, Nevada Health Authority), municipal systems (San Mateo Medical Center in California, City of Phoenix), sheriff's offices (Boulder County, Seminole County), school districts (Parkway School District), and special-purpose districts (Sourcewell cooperative procurement). The Nevada Health Authority issued two major procurements—a Program of All Inclusive Care for the Elderly (PACE) opportunity (RFP 41NHA-S4038, proposals due December 10, 2026) and a Rural Value Acceleration Network facilitation contract (RFP 41NHA-S4031, proposals due November 30, 2026)—both representing substantial managed care and systems coordination work rather than procedural intervention services. Geographic activity concentrates in California, Georgia, Nevada, Florida, Colorado, Texas, and the District of Columbia, with scattered municipal and county procurement across other states. The code appears to function as a catch-all placeholder for health services procurement broadly and does not reflect material recent activity in the specific clinical domain of biliary or pancreatic therapeutic substance introduction.